Culture method for improving proliferation and survival rate of stem cells and MMP hydrogel
By using MMP hydrogel in stem cell culture to simulate the cell microenvironment, the problem of harsh environment and low survival rate during stem cell culture is solved, and efficient cell proliferation and survival rate is achieved, which simplifies operation and reduces costs. Large-scale production and clinical application.
Patent Information
- Application Number
- CN202411364118.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-28
- Publication Date
- 2024-11-12
AI Technical Summary
During stem cell culture, the low cell survival rate is caused by the strict requirements on environmental conditions, the use of a large number of animal-derived biological materials and complex operations, which affects the reliability and repetition of experiments. The prior art has problems such as pollution to the environment and limited resources.
The cell survival rate and proliferation of cells were significantly improved by using MMP hydrogel to simulate the cell microenvironment under 37°C and 5% CO2 conditions. abilities and simplify the development steps.
It significantly improves the survival rate and proliferation ability of stem cells, reduces production costs, simplifies operations, improves the repeatability of the process, and is conducive to large-scale production and clinical applications, while reducing environmental pollution.
Smart Images

Figure CN118931832A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to stem cell culture technology, and in particular to a culture method and MMP hydrogel for improving stem cell proliferation and survival rate. Background Art
[0002] Stem cells refer to cells that permanently maintain the ability to proliferate and replicate themselves. They have the ability to differentiate into different series of cells and are a primitive and undifferentiated cell type in the human body. Stem cells are mainly divided into two categories: embryonic stem cells and adult stem cells. Embryonic stem cells have the ability to differentiate into various tissues and various stem cells, while adult stem cells have different differentiation potentials depending on their sources, such as hematopoietic stem cells, mesenchymal stem cells in the bone marrow, neural stem cells, and liver stem cells.
[0003] Mesenchymal stem cells are a type of multipotent stem cells with the ability of self-renewal and multidirectional differentiation, mainly existing in connective tissue and organ stroma, including bone marrow, placenta, umbilical cord, fat, mucosa, bone, muscle, lung, liver, pancreas and other tissues, as well as amniotic fluid, amniotic membrane, umbilical cord blood, etc. Mesenchymal stem cells can differentiate into osteoblasts, chondrocytes, adipocytes, muscle cells, nerve cells, hepatocytes, endothelial cells and other cell types under appropriate in vivo or in vitro environments.
[0004] Mesenchymal stem cells can interfere with the function of dendritic cells and inhibit the proliferation of T cells and their immune response through cell-to-cell interactions and the production of cytokines, thereby playing a role in immune reconstruction. They can be isolated from a variety of tissues and are easy to separate, culture, amplify and purify. They still have stem cell characteristics after multiple passages and amplifications.
[0005] In the prior art, a large amount of culture medium, serum and other biological materials are required in the process of stem cell culture. These materials are often derived from animals. Not only are the resources limited, but their production process may also cause environmental pollution. At the same time, the waste treatment after culture also increases the environmental burden.
[0006] Stem cell culture has extremely stringent requirements on environmental conditions, involving aseptic operation, precise temperature and humidity control, and complex culture steps, all of which place high demands on the skills and experience of operators. Different types of stem cells have different requirements for culture conditions, further increasing the complexity of the operation;
[0007] During the stem cell culture process, various factors such as unstable culture conditions, microbial contamination, and chemical residues often lead to low cell survival rates, affecting the reliability and repeatability of the experiment. Summary of the invention
[0008] The purpose of the present invention is to provide a culture method and MMP hydrogel for improving stem cell proliferation and survival rate, so as to solve the above-mentioned deficiencies in the prior art.
[0009] In order to achieve the above object, the present invention provides the following technical solution: a culture method and MMP hydrogel for improving stem cell proliferation and survival rate, comprising the following steps:
[0010] S1. First, bone marrow mesenchymal stem cells are isolated and cultured;
[0011] S2, freezing the bone marrow mesenchymal stem cells for future use;
[0012] S3. Use MMP hydrogel to culture bone marrow mesenchymal stem cells.
[0013] Furthermore, the method of culturing bone marrow mesenchymal stem cells by using MMP hydrogel as described in S3 comprises the following steps:
[0014] S31, injecting the MMP hydrogel into a sample bottle, letting it stand and then inverting it to evaluate fluidity; adding the MMP hydrogel to a syringe and injecting it with a needle to evaluate injectability; using a rheometer to measure the viscoelasticity of the MMP hydrogel at room temperature;
[0015] S32, adding 10% sterile injectable MMP hydrogel solution into a culture bottle, culturing at 37° C. for 24 hours, then inoculating bone marrow mesenchymal stem cells, and culturing them in an incubator for 24 hours;
[0016] S33. After the culture is completed, the growth of the bone marrow mesenchymal stem cells wrapped in the MMP hydrogel is observed under a microscope. When the bone marrow mesenchymal stem cells are "feather-shaped" and the fusion rate reaches 80%-90%, it proves that the bone marrow mesenchymal stem cells grow stably in the MMP hydrogel.
[0017] Furthermore, the specification of the syringe in S31 is 1 mL.
[0018] Furthermore, the needle specification of S31 is 26G.
[0019] Furthermore, the culture conditions in the incubator described in S32 are 37° C. and a CO 2 content of 5%.
[0020] Furthermore, the separation of bone marrow mesenchymal stem cells in S1 comprises the following steps:
[0021] S11. Two SD rats were killed by dislocating the neck, and the rats were soaked in 75% ethanol. After soaking, the remaining 75% ethanol was rinsed off with saline;
[0022] S12. Fully expose the bilateral tibia, femur and bone marrow cavity of the rats in strict accordance with aseptic techniques, and flush the bone marrow cavity 3-4 times with phosphate buffered saline;
[0023] S13, collecting the bone marrow cavity flushing fluid, mixing, filtering and centrifuging in sequence, resuspending the cells in L-DMEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin double antibody, then inoculating them into a T25 cell culture dish, and incubating them in a cell culture incubator;
[0024] S14. The medium was changed for the first time after 2 days of incubation, and then the medium was changed every 3 days. When the cell growth and fusion reached 90%-100%, the cells were digested with 0.25% trypsin-EDTA digestion solution. The P3 cell culture was carried out for adipogenic and osteogenic differentiation, and the cell surface antigens CD45, CD29, CD34 and CD90 were detected by flow cytometry.
[0025] Furthermore, the SD rats described in S11 are 4-week-old SD rats weighing 200-300 g.
[0026] Furthermore, the step S2 of freezing and preserving the bone marrow mesenchymal stem cells for future use comprises the following steps:
[0027] S21, preparing a freezing storage solution;
[0028] S22, select the third generation cells, wash them repeatedly with PBS, add 0.2% trypsin to digest them, collect the cell suspension and centrifuge it;
[0029] S23, discard the supernatant and resuspend the cells in fresh culture medium;
[0030] S24. Add an equal amount of freezing preservation solution dropwise to the removed cell suspension and gently pipette until uniform. After adjusting the cell concentration, put it into a 1 mL EP tube and then freeze it in -80℃ liquid nitrogen for later use.
[0031] Furthermore, the preparation step of the cryopreservation solution in S21 is: adding L-DMEM culture medium, serum, dimethyl sulfoxide and a 20% cryopreservation solution in a centrifuge tube in sequence at room temperature.
[0032] Furthermore, the cell concentration in S24 is 1 to 5×10 6 Pieces / mL.
[0033] Compared with the prior art, the present invention provides a culture method and MMP hydrogel for improving stem cell proliferation and survival rate. By adopting the degradable and highly biocompatible matrix material MMP hydrogel, the accurate simulation and dynamic regulation of the stem cell microenvironment are achieved, thereby significantly improving the survival rate and proliferation ability of the cells, and effectively prolonging the retention time of stem cells in vitro. The culture method is simple and fast, does not require complex equipment or harsh conditions, reduces production costs, improves the repeatability of the process, is green and environmentally friendly, and is conducive to large-scale production and clinical applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can also be obtained based on these drawings.
[0035] Figure 1 A schematic diagram of the separation, culture and identification of bone marrow mesenchymal stem cells provided in an embodiment of the present invention;
[0036] Figure 2 Ultrasonic in vitro images, immunofluorescence and electron microscopy scanning images of hydrogel-loaded bone marrow mesenchymal stem cells provided in an embodiment of the present invention. DETAILED DESCRIPTION
[0037] In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention will be further described in detail below with reference to the accompanying drawings.
[0038] Embodiment 1:
[0039] See also Figure 1-Figure 2 A culture method and MMP hydrogel for improving stem cell proliferation and survival rate, comprising the following steps:
[0040] S1. First, bone marrow mesenchymal stem cells are isolated and cultured;
[0041] First, two 4-week-old SD rats weighing 200-300g were killed by cervical dislocation. The rats were soaked in 75% ethanol for 10 minutes. After the soaking, the remaining 75% ethanol was rinsed with saline. The tibia, femur and bone marrow cavity of the rats were taken and fully exposed according to the aseptic operation. l Phosphate buffered saline (PBS) was drawn with a syringe to flush the bone marrow cavity 3-4 times. The bone marrow cavity flushing fluid was collected and mixed, filtered and centrifuged. The cells were resuspended in L-DMEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin double antibody, and then inoculated into a T25 cell culture dish and incubated in a cell culture incubator; the first medium change was performed after 2 days of incubation, and then the medium was changed every 3 days. When the cell growth fusion reached 90%-100%, the cells were digested with 0.25% trypsin-EDTA digestion solution, and P3 cell culture was carried out for adipogenic and osteogenic differentiation. Cell surface antigens were detected by flow cytometry, and the antigens included: CD45, CD29, CD34 and CD90.
[0042] CD45 is a transmembrane protein tyrosine phosphatase receptor (PTPRC), also known as leukocyte common antigen (LCA). In most stem cell types, CD45 expression is negative or low. For example, in mesenchymal stem cells, CD45 is usually not expressed, which is an important criterion for identifying MSCs.
[0043] CD29, also known as integrin β1, is a widely expressed cell surface protein involved in cell-to-cell adhesion and signal transduction. CD29 is expressed in a variety of stem cells, including MSCs. Its high expression rate is often used as a positive identification indicator for MSCs. The detection of CD29 helps to confirm the presence of stem cells and may be related to the adhesion, migration and differentiation functions of stem cells.
[0044] CD34 is a highly glycosylated type I transmembrane glycoprotein that belongs to the cadherin family. CD34 is expressed in hematopoietic stem cells and certain types of stem cells (such as embryonic stem cells), but is usually not expressed or expressed at a low level in MSCs.
[0045] CD90, also known as Thy-1, is a cell surface glycoprotein belonging to the immunoglobulin superfamily. CD90 is expressed in a variety of stem cells, including MSCs. Its high expression rate is also an important identification criterion for MSCs. The detection of CD90 helps to confirm the existence of stem cells and may be related to the proliferation, differentiation and migration of stem cells.
[0046] Surface antigens such as CD45, CD29, CD34 and CD90 are of great significance for the identification, classification and functional research of stem cells. The flow cytometer irradiates the cells flowing through the flow cytometer with a laser beam and measures the fluorescence intensity produced by each cell after being excited, thereby determining whether the above-mentioned specific antigens exist on the cell surface or inside the cell.
[0047] S2. Freeze and store bone marrow mesenchymal stem cells for future use:
[0048] First, prepare the cryopreservation solution. Use a centrifuge tube to add culture medium, serum, and dimethyl sulfoxide in turn at room temperature to a 20% cryopreservation solution (ratio 9:1) for later use. Select the third generation cells, wash them three times with PBS, add 1mL 0.2% trypsin, digest the cells, collect the cell suspension in a 10mL centrifuge tube, place it in a centrifuge, centrifuge it at 1000r / min for 5min, gently discard the supernatant, and then resuspend the cells with fresh culture medium. The total number of cells and cell viability are calculated using the cell suspension.
[0049] Add an equal amount of freezing solution dropwise to the removed cell suspension and gently pipette until it is uniform. Adjust the cell concentration to 1-5×10 6 / mL, and were placed in 1mL EP tubes, sealed and labeled with cell name, generation, and date. After programmed cooling, the cells were stored in -80℃ liquid nitrogen for later use.
[0050] S3. Use MMP hydrogel to culture bone marrow mesenchymal stem cells.
[0051] 2 mL of MMP hydrogel was injected into a sample vial, allowed to stand for 10 min, and then inverted to evaluate fluidity. The sample was added to a syringe (1 ml) and injected with a needle (26G) to evaluate the injectability of the hydrogel. The viscoelasticity of the sample was measured using a rheometer at room temperature.
[0052] In vitro, 10% sterile injectable MMP gelatin aqueous solution was added to the culture bottle, cultured at 37°C for 24 hours, and then inoculated with bone marrow mesenchymal stem cells, and then placed in a humidified incubator at 37°C and 5% CO2. After 24 hours, the growth of the encapsulated bone marrow mesenchymal stem cells was observed under a microscope. When the bone marrow mesenchymal stem cells were "feather-shaped" and the fusion rate reached 80%-90%, it was proved that the bone marrow mesenchymal stem cells grew stably in the MMP hydrogel. Based on this, it is clear that the MMP hydrogel has the ability to successfully carry bone marrow mesenchymal stem cells.
[0053] Embodiment 2:
[0054] See also Figure 1-Figure 2This embodiment provides a technical solution based on the first embodiment: using a confocal laser scanning microscope to observe the size, shape and growth of bone marrow mesenchymal stem cells encapsulated in the MMP hydrogel, Figure 2 The red arrows in the middle are bone marrow mesenchymal stem cells.
[0055] The detailed observation of bone marrow mesenchymal stem cells (MSCs) encapsulated in MMP hydrogels using confocal laser scanning microscopy (CLSM) not only reveals the basic morphological characteristics of cells in a three-dimensional microenvironment, but also allows for in-depth exploration of their growth dynamics and interactions.
[0056] In order to improve the observation effect of CLSM, MSCs need to be fluorescently labeled. This can be achieved by using specific cell dyes (such as GFP transgenic markers, cell membrane dyes or nuclear dyes), which can bind to different components of the cell and emit fluorescence at specific wavelengths. The labeled samples need to be properly fixed and permeabilized to maintain the cell morphology while allowing the fluorescent dye to penetrate into the cell. However, for living cell observation, fixatives that may affect cell activity should be avoided, and milder fixation techniques or direct observation should be used instead.
[0057] After starting CLSM, a high-energy laser beam is used as a light source, focusing on a point on the sample through a pinhole, and collecting the fluorescence signal reflected or emitted from the point. By scanning the entire sample area point by point and constructing a three-dimensional image, the size and shape of MSCs in the hydrogel can be clearly observed. Due to the adjustable pore structure and good biocompatibility of MMP hydrogel, MSCs can often maintain their typical spindle or flat morphology, but may also present different morphologies, such as spherical or elongated, due to changes in the microenvironment.
[0058] Further analysis of the CLSM images revealed the growth of MSCs in the hydrogel. This included cell proliferation, migration, and interaction with other cells. By quantitatively analyzing the large amount of image data acquired by CLSM, a comprehensive assessment of the growth of MSCs in MMP hydrogels can be obtained. This includes cell survival rate, proliferation rate, morphological changes, and interaction patterns with the surrounding environment.
[0059] Embodiment three:
[0060] This embodiment provides a technical solution based on the first embodiment: measuring the proliferation of bone marrow mesenchymal stem cells in the injectable MMP hydrogel by determining the deoxyribonucleic acid (DNA) content.
[0061] This method is a quantitative and precise method that can provide direct evidence of cell growth. DNA is the carrier of cellular genetic information, and its content is proportional to the number of cells. During the proliferation of MSCs, as the number of cells increases, the total amount of DNA will also increase accordingly. Therefore, by measuring the total content of DNA in the hydrogel, the proliferation of MSCs can be indirectly reflected. The DNA content determination is usually based on the binding ability of DNA to specific dyes (such as Hoechst 33258, PicoGreen, etc.), which emit fluorescence at specific wavelengths, and their fluorescence intensity is proportional to the DNA content.
[0062] In order to extract DNA from cells, the collected cells need to be lysed. During the lysis process, the cell membrane and nuclear membrane are destroyed, releasing the DNA and other nuclear substances in the cell. The extracted DNA may contain proteins, RNA and other small molecule impurities, and needs to be purified to ensure a high-purity DNA sample. Select a suitable DNA-specific dye. During the reaction, DNA combines with the dye to form a stable complex, which emits fluorescence at a specific wavelength.
[0063] Use a fluorescence spectrophotometer or fluorescence microplate reader to measure the fluorescence intensity of the sample. Set appropriate excitation wavelengths and emission wavelengths to ensure accurate measurement of the fluorescence signal of the DNA-dye complex. Calculate the DNA content in the sample based on the standard curve (the relationship between samples with known DNA concentration and fluorescence intensity). The standard curve should be validated before use to ensure its accuracy and reliability. By comparing the DNA content of samples at different time points, the proliferation of MSCs in MMP hydrogels can be evaluated. An increase in DNA content indicates an increase in the number of cells, i.e., cell proliferation.
[0064] Embodiment 4:
[0065] This embodiment provides a technical solution based on the first embodiment: Cell migration-Transwell experiment:
[0066] The injectable MMP hydrogel carrying bone marrow mesenchymal stem cells was inoculated into the upper chamber of a 24-well Transwell. The MSCs penetrating the surface of the hydrogel were fixed and stained with crystal violet, and then the migration rate was observed under a microscope.
[0067] Cell migration is a crucial process in biological research, which involves the ability of cells to move from one place to another in response to external signals or environmental changes. In the field of stem cell therapy and tissue engineering, the migration ability of bone marrow mesenchymal stem cells (MSCs) is crucial for their effective homing to the site of injury and exerting therapeutic effects.
[0068] Inoculate the injectable MMP hydrogel carrying bone marrow mesenchymal stem cells into the upper chamber of a 24-well Transwell, paying attention to controlling the volume and shape of the hydrogel to ensure that it can evenly cover the membrane surface and does not overflow. At the same time, avoid introducing bubbles or damaging cells during the inoculation process.
[0069] Place the inoculated Transwell chamber in a cell culture incubator and culture under appropriate temperature, humidity and gas conditions. Remove the Transwell chamber for observation at a predetermined time point according to the experimental design. Before observation, it may be necessary to remove the culture medium and hydrogel residue in the upper chamber in order to clearly see the cells on the membrane surface.
[0070] In order to observe the migration of MSCs, the cells that pass through the hydrogel surface and adhere to the membrane surface need to be fixed and stained. Commonly used fixatives include methanol, formaldehyde, etc., and crystal violet is often used as a stain. The fixative is added to the upper chamber, removed after standing for a period of time, and then the cells are stained with a stain. The staining time should be optimized according to the characteristics of the stain and the cell type.
[0071] Place the stained Transwell chamber under a microscope for observation. By adjusting the focus and magnification of the microscope, the cell morphology and distribution on the membrane surface can be clearly seen. Use the camera function of the microscope to record the cell migration at different time points for subsequent data analysis and comparison.
[0072] In order to quantify the migration ability of MSCs, the migration rate can be calculated. The migration rate is usually defined as the ratio of the number of cells that pass through the membrane surface to the total number of cells. In actual operation, the migration rate can be estimated by counting the number of cells on the membrane surface (such as using a cell counter or image processing software). At the same time, a control group is set up to compare the migration ability of cells under different conditions.
[0073] The Transwell experiment can be used to effectively evaluate the migration behavior of MSCs in a specific matrix. This experiment not only provides an important in vitro model for the study of stem cell therapy and tissue engineering, but also provides an experimental basis for optimizing the migration performance of MSCs.
[0074] Embodiment five:
[0075] See also Figure 2 This embodiment provides a technical solution based on the first embodiment: In vitro ultrasound imaging experiment:
[0076] Ultrasound imaging is a non-invasive, radiation-free imaging technology that uses the propagation and reflection characteristics of ultrasound in a medium to receive and process reflected ultrasound signals through electronic devices to form images. When observing stem cells in hydrogels, ultrasound will penetrate the hydrogel and interact with the stem cells and surrounding matrix to generate echo signals. After processing, these signals can form images that reflect the distribution and status of stem cells. Through in vitro ultrasound imaging technology, the growth, distribution and differentiation of stem cells in hydrogels can be clearly displayed, and the feasibility and effectiveness of hydrogels as stem cell growth scaffolds can be evaluated.
[0077] The above description is only by way of illustration of certain exemplary embodiments of the present invention. It is undoubted that those skilled in the art can modify the described embodiments in various ways without departing from the spirit and scope of the present invention. Therefore, the above drawings and descriptions are illustrative in nature and should not be construed as limiting the scope of protection of the claims of the present invention.
Claims
1. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate, characterized in that: The steps include: S1. First, bone marrow mesenchymal stem cells are isolated and cultured; S2, freezing the bone marrow mesenchymal stem cells for future use; S3. Use MMP hydrogel to culture bone marrow mesenchymal stem cells.
2. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 1, characterized in that: S3 described in the method of using MMP hydrogel to culture bone marrow mesenchymal stem cells comprises the following steps: S31, injecting the MMP hydrogel into a sample bottle, letting it stand and then inverting it to evaluate fluidity; adding the MMP hydrogel to a syringe and injecting it with a needle to evaluate injectability; using a rheometer to measure the viscoelasticity of the MMP hydrogel at room temperature; S32, adding 10% sterile injectable MMP hydrogel solution into a culture bottle, culturing at 37° C. for 24 hours, then inoculating bone marrow mesenchymal stem cells, and culturing them in an incubator for 24 hours; S33. After the culture is completed, the growth of the bone marrow mesenchymal stem cells wrapped in the MMP hydrogel is observed under a microscope. When the bone marrow mesenchymal stem cells are "feather-shaped" and the fusion rate reaches 80%-90%, it proves that the bone marrow mesenchymal stem cells grow stably in the MMP hydrogel.
3. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 2, characterized in that: The specification of the syringe in S31 is 1 mL.
4. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 2, characterized in that: The needle specification of S31 is 26G.
5. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 2, characterized in that: The culture conditions in the incubator of S32 are 37° C. and a CO 2 content of 5%.
6. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 1, characterized in that: The separation of bone marrow mesenchymal stem cells described in S1 comprises the following steps: S11. Two SD rats were killed by dislocating the neck, and the rats were soaked in 75% ethanol. After soaking, the remaining 75% ethanol was rinsed off with saline; S12. Fully expose the bilateral tibia, femur and bone marrow cavity of the rats in strict accordance with aseptic techniques, and flush the bone marrow cavity 3-4 times with phosphate buffered saline; S13, collecting the bone marrow cavity flushing fluid, mixing, filtering and centrifuging in sequence, resuspending the cells in L-DMEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin double antibody, then inoculating them into a T25 cell culture dish, and incubating them in a cell culture incubator; S14. The medium was changed for the first time after 2 days of incubation, and then the medium was changed every 3 days. When the cell growth and fusion reached 90%-100%, the cells were digested with 0.25% trypsin-EDTA digestion solution. The P3 cell culture was carried out for adipogenic and osteogenic differentiation, and the cell surface antigens CD45, CD29, CD34 and CD90 were detected by flow cytometry.
7. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 6, characterized in that: The SD rats described in S11 are 4-week-old SD rats weighing 200-300 g.
8. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 1, characterized in that: S2, freezing and preserving the bone marrow mesenchymal stem cells for future use, comprises the following steps: S21, preparing a freezing storage solution; S22, select the third generation cells, wash them repeatedly with PBS, add 0.2% trypsin to digest them, collect the cell suspension and centrifuge it; S23, discard the supernatant and resuspend the cells in fresh culture medium; S24. Add an equal amount of freezing preservation solution dropwise to the removed cell suspension and gently pipette until uniform. After adjusting the cell concentration, put it into a 1 mL EP tube and then freeze it in -80℃ liquid nitrogen for later use.
9. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 8, characterized in that: S21 The preparation steps of the freezing preservation solution are: adding L-DMEM culture medium, serum, dimethyl sulfoxide and a freezing solution with a concentration of 20% in a centrifuge tube in sequence at room temperature.
10. A culture method and MMP hydrogel for improving stem cell proliferation and survival rate according to claim 8, characterized in that: The cell concentration of S24 is 1 to 5×10 6 Pieces / mL.
